Diabetes Flashcards

1
Q

What is Diabetes Mellitus?

A

•Collection of diseases of glucose homeostasis

  • Type 1 Diabetes (T1DM)
  • Type 2 Diabetes (T2DM)
  • Type 3c
  • MODY
  • Gestational Diabetes
  • T2DMY
  • Others
  • Accounts for 10% of NHS budget
  • Associated with serious complications
  • Shortens lifespan/accelerates ageing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diabetes Diagnosis – FBG/OGTT

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diabetes Diagnosis – HbA1c

A

Glucose binds irreversibly to Hb in

erythrocytes, forming HbA1c

  • The higher the glucose, the higher the HbA1c
  • HbA1c reflects the prevailing blood glucose

over the preceding 2-3 months

  • Diagnosis:
  • HbA1c mmol/mol
  • Normal <42 mmol/mol
  • ‘Prediabetes’ 42 to 47 mmol/mol
  • Diabetes 48 mmol/mol or >
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

History of Diabetes

A

•First described in Ebers Papyrus

  • One of only a few diseases mentioned
  • Notes 3 types of healers (physicians, surgeons and Sorcerers)!
  • No mention of glucose

Treatment was: a measuring glass filled with water from the bird

pond, elderberry, fibres from the asit plant,

fresh milk, beer swill, flower of the cucumber and

green dates’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe normal glucose homeostasis post prandially

A

Insulin is key hormone (glucagon and somatostatin also)

Post-prandially (fed)

  • Glucose comes from GI tract via SGLT1
  • Glucose stimulates insulin release from pancreatic-β cells (islets)
  • Insulin promotes glucose uptake in hepatocytes (minor), skeletal muscle (major) and adipocytes and inhibits release of glucose from stores
  • Glucose is stored as metabolites – anabolism occurs )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe normal glucose homeostasis in the fasting state

A
  • Glucose drops – lowering insulin
  • Insulin repression of glucose release lessens - catabolism occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe insulin production

A

•Insulin is produced by pancreatic beta-cells

  • 51aa peptide comprising 2 chains (A and B)
  • Synthesised on RER as pre-proinsulin
  • Signal peptide removed before transfer to Golgi
  • Cleaved by PC1/3 to form mature insulin
  • Stored in secretory granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe insulin release

A
  • Nutrient response (glucose primarily) – biphasic pattern
  • Large role for incretins???
  • Basal secretion does occur (<1.5U/h)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is insulin secretion increased by?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Draw a graph of insulin secretion

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are inretins?

A
  • Gut hormones that regulate insulin secretion
  • GLP-1 thought to be responsible for >60% of insulin response to glucose
  • Short half life (2-3 minutes) due to DPP-IV
  • New classes of drugs

GLP-1 analogues

DPP-IV inhibitors

•Recent research

Combined GLP-1 and GIP (LY3298176) may be best ever treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of intecrins

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T1DM

A
  • <10% of cases
  • Primarily children and adolescents
  • Cause not understood
  • Almost absolute insulin deficiency – T-cell

mediated autoimmune destruction of pancreatic β-cells

  • Incidence varies dramatically
  • Genetic factors – HLA class II DR-3/-4

(95% of European T1DM)

•GWAS studies – INS promoter, PTPN2, IL2Ra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presentation of T1DM:

A
  • Short illness (1-4 weeks)
  • Classical diabetes symptoms (polyurea, polydipsia, fatigue weight loss)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the risk of developing type 1 diabetes for relatives of people with type 1 diabetes

A
17
Q

Describe type 2 diabetes (T2DM)

A

•The commonest form of diabetes

  • 300 million people worldwide (3 million in UK)
  • Heterogeneous
  • Interaction between genetic predisposition and environment
  • Combination of insulin resistance and pancreatic β-cell dysfunction
  • Traditionally found in older adults
  • Lifetime risk of 1/10
  • In some parts of USA, T2DM as common
  • as T1DM in teenagers
18
Q

TRUE or FALSE: T2DM has greater heritability than T1DM

A
  • Approx. 40-80% of susceptibility
  • More maternal than paternal
  • Several gene polymorphisms identified as increasing risk (see box)
19
Q

What are the key environmental factors of T2DM?

A
  • Obesity – 80% of new cases
  • Physical inactivity
  • Foetal development
  • Ageing
  • These factors drive insulin resistance
20
Q

What is the key cause of T2DM?

A

Insulin resistance

Defined as the inability of insulin to produce its usual biological effects

↓ inhibition of hepatic glucose output

↓ ability to stimulate glucose uptake in muscle and adipose tissue

↓ suppression of lipolysis →

•Potential mechanisms

  • ↓ number of insulin receptors
  • Abnormal insulin receptors
  • Abnormal post-receptor signalling
  • Abnormal GLUT-4 translocation

Lipotoxicity is the key mechanism

21
Q

Define Β-cell Dysfunction

A
  • Loss of β-cell function is the KEY DIAGNOSTIC EVENT
  • Insulin resistance cannot explain the whole story!

Most T2DM are no more insulin resistant that most insulin resistant quartile of general population

Only 20% of insulin resistant people get T2DM

•Causes

Glucolipotoxicty

Genetics

Hormonal – incretins

Obesity

22
Q

Describe the natural history of Diabetes

A
23
Q

What is the main treatment for T1DM?

A

Insulin

24
Q

What is the lifestyle changes help with T2DM?

A
  • Diet
  • VLCD
  • Exercise
25
Q

T2DM treatments: Oral antidiabetics

A
  • Secretagogues
  • Sensitisers
  • Inhibitors of glucose absorption
  • Incretin therapies
26
Q

T2DM treatment: Insulin analogues

A

Long/short acting insulins

27
Q

T2DM treatments: Novel drugs

A
  • SGLT2 inhibitors
  • GLP-1 analogues
  • DPP4 inhibitors
  • GLP-1-GIP combined therapies
28
Q
A
29
Q

Dsecribe microvascular complications

A
  • Affect 80% of people with diabetes
  • Already present in 20-50% of newly diagnosed T2DM
  • Causes – hyperglycaemia (AGEs, sorbitol pathway etc)
  • Retinopathy, nephropathy, neuropathy, diabetic foot
30
Q

Describe macrovascular complications

A
  • Large blood vessels (coronary arteries, aorta, larger arteries in brain/limbs)
  • Commonly – heart disease, cerebrovascular disease, peripheral vascular disease
  • Normally atherosclerosis
  • Diabetes = 4-fold ↑ risk of MI in men, 10-fold in women
  • Causes 65% of all deaths in diabetes.
31
Q

Symptoms of T2DM

A

Retinopathy

  • Most common cause of blindnes in people of working age

Nephropathy

  • 20-44% of all new patients needing renal replacement therapy have diabetes

Erectile dysfunction

  • May affect up to 50% of men ith long-standng diabetes

Macrovascular disease

  • 2-3 fold increase risk of coronary heart disease and stroke

Foot problems

  • 15% of people with diabetes develop foot ulcers; 5-15% of people with diabetic foot ulcers need amputations
32
Q

TRUE or FALSE: T1DM can be prevented

A

FALSE

33
Q

How can T2DM be prevented?

A
  • Screening and aggressive treatment of IGT
  • Increase physical activity
  • Reduce carb/fat load
  • Fasting?
  • Drugs
34
Q
A
35
Q

Lifestyle changes that help with T2DM

A
36
Q

Pharmacological T2DM prevention

A